Just another medical committee that does seem to understand the difference between dosages and effectiveness. The should be sent back to medical school. Not to mention they know nothing about the importance of EPA/AA ratios. The Japanese Scientists are clearly way ahead of these so called experts.
Definition of EXPERT.
Someone who knows more and more, about less and less.
Thanks … excellent new … I guess the 2nd best all-time.
After EU approval Vascepa will be the one and only O3 product that will be considered by the EMA as effective in preventing heart disease and the one and only O3 product that will be authorized for such use.
The currently available, approved products built the market but they have to amend the label now.
As the European reimbursement and prescription method is different than the US it will effect these products negatively and will boost Vascepa sales (as the "current" O3 script will be replaced with Vascepa script).
Market Data 
Markets 
AI
